Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2

Uchiyama, Shinichiro; Shinohara, Yukito; Katayama, Yasuo; Yamaguchi, Takenori; Handa, Shunnosuke; Matsuoka, Kempei; Ohashi, Yasuo; Tanahashi, Norio; Yamamoto, Hiroko; Genka, Chokoh; Kitagawa, Yasuhisa; Kusuoka, Hideo; Nishimaru, K; Tsushima, Motoo; Koretsune, Yukihiro; Sawada, Tohru; Hamada, Chikuma; the CSPS 2 group, for

doi:10.1159/000360811

Public

Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2

Published in Cerebrovascular Diseases • Jan 1, 2014

Authors:

Shinichiro Uchiyama

Yukito Shinohara

Yasuo Katayama

Abstract

BACKGROUND: The Cilostazol Stroke Prevention Study 2 (CSPS 2) showed that cilostazol significantly reduced the risk of stroke by 25.7% relative to aspirin, with significantly fewer hemorrhagic events, in patients with prior ischemic stroke, excluding cardioembolic stroke. However, whether the benefi...

Subject

Medicine

Cilostazol

Stroke (engine)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!